glp 1 drugs pros and cons & of GLP-1 weight loss GLP-1 Medications for Weight Loss:

People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use GLP-1 medications

Fact : In July 2023, the European Medicines Agency began reviewing reports of patients causing self-harm or having suicidal ideation after taking weight-loss drugs that contain semaglutide

In terms of constipation, except for Danuglipron, which was lower than the placebo, the incidence rates for other GLP-1RA drugs were similar to or higher than those for the placebo

16 Based on this pharmacology setmelanotide is prescribed alongside diet and exercise to facilitate weight loss and enhance quality of life in patients with genetic disorders of obesity